SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.83 / 10
Netural
With a fund flow rating of 7.63/10, the stock shows robust fund flow characteristics. Supportive momentum from no significant trends is partially offset by concerning overall, block, Small, Medium, Large, and Extra-large patterns, pointing to positive capital flow trajectory. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-16
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of SLN?
- SLN holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.83/10 (Netural).
